Minnesota Implications: Case of Burnett v. NAR et al

Frontiers Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment

Commissions Come Under Fire In 2023

A Discussion on the Burnett v NAR et al Lawsuit

Irisin acts through its integrin receptor in a two-step process involving extracellular Hsp90α - ScienceDirect

Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs

The contribution of alpha synuclein to neuronal survival and function – Implications for Parkinson's disease - Benskey - 2016 - Journal of Neurochemistry - Wiley Online Library

Jury Finds NAR, Brokerages Guilty in Sitzer Commissions Suit

New Members – February 2021 – SPAAR

Josh McFall, CAE, RCE on LinkedIn: We've been certified as a Great Place To Work US organization! This…

Glia, Neurobiology Journal